Tenderwize
Wróć do wyszukiwania

Non-exclusive discount agreement for Propofol (N01AX10)

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Jun 27, 2028 · 674 days left·Open·Supplies·Framework
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V für die im Rahmen des Sprechstundenbedarfs in Niedersachsen verordnungs- und abgabefähigen Arzneimittel mit dem Wirkstoff Propofol (ATC-Code: N01AX10).

50/100

Ocena szansy

Needs reviewLow complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

50 / 100

Złożoność

25 / 100

Czynniki ryzyka

The notice explicitly states it is not a public contract, limiting recourse to procurement review bodies. Legal challen...

No estimated value stated; potential for low or no revenue if prescribers do not choose the product.

No procurement documents available

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Aug 2028
  • Enter into a non-exclusive discount agreement for the active ingredient Propofol (ATC N01AX10) for physician’s office supplies in Lower Saxony.
  • The agreement is under an open-house model: all qualified pharmaceutical entrepreneurs may join on identical terms, with no selection or negotiation.
Pokaż pełne podsumowanie

This is an open-house non-exclusive discount agreement (Rabattvertrag) for the active ingredient Propofol (ATC: N01AX10) for physician's office supplies (Sprechstundenbedarf) in Lower Saxony, Germany. The contracting authority is AOK Niedersachsen. The agreement is not a public procurement but a transparent open-house model where all qualified pharmaceutical entrepreneurs can join. The agreement period is from 01.09.2026 to 31.08.2028, with rolling entry possible on the first of each month. The first deadline for initial contracts is 28.07.2026. No estimated value is provided.

Ryzyka

The notice explicitly states it is not a public contract, limiting recourse to procurement review bodies. Legal challen...

No estimated value stated; potential for low or no revenue if prescribers do not choose the product.

No procurement documents available

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Must be a pharmaceutical entrepreneur as defined in §4(18) AMG or a consortium of such entrepreneurs.
  • Must have a registered seat in Germany, an EU member state, or an EEA state.
  • Local representatives can only participate if they themselves are pharmaceutical entrepreneurs.

Wymagania mogą być niepełne.

Zamawiający

Lokalizacja

Hannover, DEU

Identyfikator

AOK- Niedersachsen. Die Gesundheitskasse

Działalność

Health

Części (1)

LOT-0000

Non-exclusive discount agreement for Propofol (N01AX10)

This lot covers the conclusion of non-exclusive discount agreements for Propofol preparations in Lower Saxony under the open-house model. All interested pharmaceutical entrepreneurs can join with uniform conditions. No selection or competition.

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

DE929, Germany

Czas trwania

Aug 2026 - Aug 2028

Kategoria

Pharmaceutical products

Termin

Deadline Jun 27, 2028

Szczegóły zamówienia

Data publikacji
05 Jul 2026
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
460781-2026

Podobne przetargi